Fingolimod: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fingolimod. Educational only — not medical advice.
Labeled uses
Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
Source: FDA labeling via NIH DailyMed (set 6c0faf2b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.